Viridian Therapeutics
VRDN
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.00 | -0.81 | 0.19 | 19.00% |
| Revenue | 48.8K | 72.0K | 23.2K | 47.63% |
WhatIF - Earnings
EPS Beat Expectations by $0.19
Viridian Therapeutics (VRDN:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything